Promega Target Engagement kinase profiling live in January 2019!

Re-energise your kinase discovery programme

  • Do you want to evaluate your compound binding against a panel of kinases in a cellular environment?
  • Do you want to understand the kinetic profile of your compound?
  • How does your compound behave in a physiological environment (e.g. ATP concentration)?
  • How selective is your compound?

If the answer to any of these questions is important to your drug discovery programme, then we might have the perfect solution for you!

Aurelia Bioscience offers compound profiling services using Target Engagement (TE) Intracellular Kinase Assays to help you make better choices in selecting your lead molecule.

Target Engagement (TE) Intracellular Kinase Assays

Using Promega’s NanoBRET™ technology, we have implemented intracellular kinase assays designed to study the interaction of compounds on kinase targets in intact living cells.

NanoBRET™ Target Engagement Assay measures compound binding at specific target kinases. This quantitative analysis can be performed in cultured cells via energy transfer between a 19-kDa luciferase (NanoLuc, Nluc)-tagged target protein and a cell-permeable fluorescent energy transfer probe introduced to the assay medium. Addition of competing compounds results in a dose-dependent decrease in NanoBRET™ signal, which allows quantification of the intracellular affinity of the target kinase for the test compound.

Some of the advantages of this technique are:

  • First biophysical technique to profile compound binding for intracellular targets – truly functional pharmacology assay
  • Intracellular examination of compound binding to target kinase at physiological ATP concentrations in live cells
  • Expression of full length kinase target in cells
  • Examines the K-on (association rate) and K-off (dissociation rate) with kinase:

         – evaluates kinetic selectivity which may drastically differ between kinases in living cells

         – equilibrium analysis may fail to predict target occupancy in an open system versus a cellular environment

  • The kinase selectivity profile may differ in a biochemical assay compared to a cellular environment due to target occupancy
  • Cells can be disrupted (with digitonin) to release cellular content from the cell and the assay can be performed as a pseudo biochemical binding assay

         – allows comparison of biochemical versus live cell occupancy binding and affinity

  • The approach can be used to look at allosteric inhibitors in addition to ATP competitive inhibitors
  • The approach can be used for screening many compounds against one kinase (HTS) or many kinases against one compound (SAR)
  • Assay may be used for kinome wide screening of compounds for intracellular target efficacy and off target effects

Example data for DDR1 Kinase:

By studying both the association and dissociation rate of compounds from a target kinase, it is possible to consider introducing kinetic binding parameter evaluation during compound SAR development.

Kinase panel:

If your 'kinase of interest' is not on the list, let us know- our list is being updated constantly:

Are you looking to screen your compounds against specific kinase targets?

Share This